Autobio Diagnostics Co Ltd
SSE:603658

Watchlist Manager
Autobio Diagnostics Co Ltd Logo
Autobio Diagnostics Co Ltd
SSE:603658
Watchlist
Price: 44.2 CNY -6.04% Market Closed
Market Cap: 25.3B CNY
Have any thoughts about
Autobio Diagnostics Co Ltd?
Write Note

Autobio Diagnostics Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Autobio Diagnostics Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Autobio Diagnostics Co Ltd
SSE:603658
Cash from Operating Activities
ÂĄ1.4B
CAGR 3-Years
2%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Cash from Operating Activities
ÂĄ2.7B
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Cash from Operating Activities
ÂĄ212.6m
CAGR 3-Years
20%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Cash from Operating Activities
ÂĄ1.1B
CAGR 3-Years
-39%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Cash from Operating Activities
ÂĄ1.4B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Intco Medical Technology Co Ltd
SZSE:300677
Cash from Operating Activities
ÂĄ775.5m
CAGR 3-Years
-60%
CAGR 5-Years
31%
CAGR 10-Years
N/A
No Stocks Found

Autobio Diagnostics Co Ltd
Glance View

Market Cap
25.7B CNY
Industry
Health Care

Autobio Diagnostics Co., Ltd. engages in the research, development, manufacturing, integration, service, and distribution of in vitro diagnostic reagents and instruments. The company is headquartered in Zhengzhou, Henan and currently employs 5,031 full-time employees. The company went IPO on 2016-09-01. The firm's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The firm distributes its products in domestic markets.

Intrinsic Value
78.4 CNY
Undervaluation 44%
Intrinsic Value
Price

See Also

What is Autobio Diagnostics Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.4B CNY

Based on the financial report for Jun 30, 2024, Autobio Diagnostics Co Ltd's Cash from Operating Activities amounts to 1.4B CNY.

What is Autobio Diagnostics Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
16%

Over the last year, the Cash from Operating Activities growth was -6%. The average annual Cash from Operating Activities growth rates for Autobio Diagnostics Co Ltd have been 2% over the past three years , 16% over the past five years .

Back to Top